Karateev, D. E. (2014). A new trend in pathogenetic treatment of rheumatoid arthritis: Tofacitinib, the first inhibitor of Janus kinase. IMA-PRESS LLC.
Chicago Style (17th ed.) CitationKarateev, Dmitry Evgenyevich. A New Trend in Pathogenetic Treatment of Rheumatoid Arthritis: Tofacitinib, the First Inhibitor of Janus Kinase. IMA-PRESS LLC, 2014.
MLA (9th ed.) CitationKarateev, Dmitry Evgenyevich. A New Trend in Pathogenetic Treatment of Rheumatoid Arthritis: Tofacitinib, the First Inhibitor of Janus Kinase. IMA-PRESS LLC, 2014.
Warning: These citations may not always be 100% accurate.